Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Statements of Cash Flows (Unaudited)

v3.22.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities    
Net loss $ (45,333) $ (39,070)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Impairment of other long-lived assets 3,865
Depreciation and amortization 29,924 27,695
Stock-based compensation 17,364 15,182
Foreign currency transaction loss 10,318 3,311
Share in loss of associated companies 174 2,549
Revaluation of investments 2,316 (1,469)
Other non-cash items, net 168 1,152
Change in cash attributable to changes in operating assets and liabilities:    
Accounts receivable, net (11,058) (4,272)
Inventories (39,162) 5,772
Other current assets and prepaid expenses 5,320 (5,066)
Other non-current assets 382 2,561
Accounts payable 10,217 24,019
Other current liabilities (20,650) 4,804
Deferred revenues 4,540 514
Deferred income taxes, net and uncertain tax positions (1,674) (5,574)
Other non-current liabilities (5,620) (3,722)
Net cash provided by (used in) operating activities (38,909) 28,386
Cash flows from investing activities    
Cash paid for acquisitions, net of cash acquired (6,669)
Purchase of property and equipment (7,526) (11,358)
Investments in short-term bank deposits (195,429) (179,000)
Proceeds from short-term bank deposits 272,000 27,000
Purchase of intangible assets (965) (564)
Other investing activities 122 (85)
Investments in unconsolidated entities (5,030) (7,000)
Net cash provided by (used in) investing activities 63,172 (177,676)
Cash flows from financing activities    
Proceeds from public offering, net of issuance costs 218,875
Proceeds from exercise of stock options 247 3,516
Payment of contingent consideration (1,386)
Other financing activities 275 405
Net cash provided by (used in) financing activities (864) 222,796
Effect of exchange rate changes on cash, cash equivalents and restricted cash (7,413) (1,869)
Net change in cash, cash equivalents and restricted cash 15,986 71,637
Cash, cash equivalents and restricted cash, beginning of period 243,293 272,216
Cash, cash equivalents and restricted cash, end of period 259,279 343,853
Supplemental disclosures of cash flow information:    
Transfer of inventory to fixed assets 1,150 2,024
Transfer of fixed assets to inventory 123 252
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:    
Cash and cash equivalents 255,886 343,733
Restricted cash included in other current assets 160 120
Cash balances classified as Held for sale 3,233
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows $ 259,279 $ 343,853